DNA mismatch repair gene MSH6 implicated in determining age at natural menopause. Hum Mol Genet. 2014;23(9):2490-7.
Perry JR, Hsu YH, Chasman DI et al.
A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. Hum Mol Genet. 2014; 23(7):1934-46.
Milne RL, Herranz J, Michailidou K et al.
Identification of New Genetic Susceptibility Loci for Breast Cancer Through Consideration of Gene-Environment Interactions. Genet Epidemiol. 2014; 38(1):84-93.
Schoeps A, Rudolph A, Seibold P et al.
Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency. Genet Med. 2014;16(1):19-24.
Murray A, Schoemaker M, Bennett CE et al.
Fine-Scale Mapping of the FGFR2 Breast Cancer Risk Locus: Putative Functional Variants Differentially Bind FOXA1 and E2F1. Am J Hum Genet. 2013; 93(6):1046-60.
Meyer KB, O'Reilly M, Michailidou K et al.
Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma. Nat Commun. 2013;4:2549.
Frampton M, da Silva Filho MI, Broderick P et al.
Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study. Endocr Relat Cancer. 2013; 20(6):875-87.
Rudolph A, Hein R, Lindström S et al.
Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors. Br J Cancer. 2013;108(11):2399-406.
Cooke R, Jones ME, Cunningham D et al.
Changes in estradiol and testosterone levels in postmenopausal women after changes in body mass index. J Clin Endocrinol Metab. 2013;98(7):2967-74.
Jones ME, Schoemaker M, Rae M et al.
A genome-wide association study of early menopause and the combined impact of identified variants. Hum Mol Genet. 2013; 22(7):1465-72.
Perry JR, Corre T, Esko T, et al.
